This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABTL1014

Ability Pharmaceuticals, SL

Drug Names(s): LP20104

Description: LP20104 is an omega-6 polyunsaturated fatty acid (PUFA) derivative.

Deal Structure: Lipopharma is the inventor of the patent covering the drug candidates being developed by Ability Pharmaceuticals.

Partners: Lipopharma Therapeutics SL


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug